TargetMol Chemicals Inc.회사는 제품 목록을 제공합니다.

회사 명:TargetMol Chemicals Inc.
전화:781-+1-781-999-5354
이메일:marketing@targetmol.com
국적:United States
URL: https://www.targetmol.com/
총 제품 수:19892

제품 카탈로그

α-Amylase알파-아밀라아제9000-90-2NULL
D-phenylalanine analogue;(R)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid103733-65-9C10H11NO2
(R)-3-Hydroxyisobutyric acid1910-47-0C4H8O3
(R)-(-)-JQ1 Enantiomer1268524-71-5C23H25ClN4O2S
3-Hydroxyisobutyric acid;(S)-3-Hydroxyisobutyric acid2068-83-9C4H8O3
ASP3026;ASP 30261097917-15-1C29H40N8O3S
(S)-Dolaphenine hydrochloride135383-60-7C11H13ClN2S
(S)-Metolachor87392-12-9C15H22ClNO2
α-Muricholic acid2393-58-0C24H40O5
Fasoracetam110958-19-5C10H16N2O2
LHW090-A71308256-94-1C20H22ClNO4
Capmatinib;INCB28060;NVP-INC280;INC-2801029712-80-8C23H17FN6O
Bikinin;Abrasin188011-69-0C9H9BrN2O3
Tubastatin A;Tubastatin A BASE1252003-15-8C20H21N3O2
DBEQ;JRF 12177355-84-9C22H20N4
Gedatolisib;PKI-587;PF-052123841197160-78-3C32H41N9O4
WAY-262611;WAY262611;WAY 2626111123231-07-1C20H22N4
GSK-5959;GSK 5959901245-65-6C22H26N4O3
PFI-4;PFI4;PFI 4900305-37-5C21H24N4O3
PH-797804;PH797804586379-66-0C22H19BrF2N2O3
Infigratinib;BGJ-398;NVP-BGJ398872511-34-7C26H31Cl2N7O3
RN4861242156-23-5C35H35FN6O3
Dorsomorphin;BML-275;Compound C866405-64-3C24H25N5O
GW627368;GW 627368X439288-66-1C30H28N2O6S
AVN-944;VX-944;AVN944297730-17-7C25H27N5O5
HA14-165673-63-4C17H17BrN2O5
3-AP;OCX191;PAN-811;NSC663249;Triapine143621-35-6C7H9N5S
CAY10603;BML-281;HDAC6 Inhibitor1045792-66-2C22H30N4O6
Cinaciguat;BAY 58-2667329773-35-5C36H39NO5
WHI-P154;Jak3 inhibitor ii211555-04-3C16H14BrN3O3
Atopaxar Hydrobromide474550-69-1C29H39BrFN3O5
PFI-2;PFI2;PFI 2;(R)-PFI-21627676-59-8C23H25F4N3O3S
Duvelisib;INK1197;IPI-1451201438-56-3C22H17ClN6O
Luminespib;AUY922;NVP-AUY922;VER-52296747412-49-3C26H31N3O5
(S)-P7C3-OMe;(R)-P7C3-Ome1235481-43-2C22H20Br2N2O2
Mertansine;DM1;Maytansinoid DM1139504-50-0C35H48ClN3O10S
J-147;J1471146963-51-0C18H17F3N2O2
Pictilisib;RG7321;GDC-0941957054-30-7C23H27N7O3S2
Fedratinib;TG-101348;SAR 302503936091-26-8C27H36N6O3S
Defactinib;PF-04554878;VS-60631073154-85-4C20H21F3N8O3S
JNJ-31020028;JNJ 31020028;JNJ310200281094873-14-9C34H36FN5O2
CHS-828;GMX1778;CHS 828200484-11-3C19H22ClN5O
Taselisib;RG-7604;GDC-00321282512-48-4C24H28N8O2
AM0951345614-59-6C27H25N2NaO5
PF-573228;PF 573228869288-64-2C22H20F3N5O3S
PF-4708671;PF 4708671;PF47086711255517-76-0C19H21F3N6
ISX-9;Isoxazole 9 (ISX-9);Isoxazole 9;Isx 9832115-62-5C11H10N2O2S
Ciproxifan maleate;FUB 359 maleate;FUB 359184025-19-2C16H18N2O2.C4H4O4
Dubermatinib;TP09031341200-45-0C24H30ClN7O2S
Omecamtiv mecarbil;CK-1827452873697-71-3C20H24FN5O3
RQ-00203078;RQ002030781254205-52-1C21H13ClF6N2O5S
LY294002;LY 294002;SF 1101;NSC 697286154447-36-6C19H17NO3
SB-3CT292605-14-2C15H14O3S2
S08591019331-10-2C29H24ClN3O3S
RKI1313;RKI-1313;RKI 13131342276-76-9C17H16N4O2S
Oclacitinib;PF-033941971208319-26-9C15H23N5O2S
Ponalrestat72702-95-5C17H12BrFN2O3
CCG-1423;CCG 1423;CCG1423285986-88-1C18H13ClF6N2O3
Fexaramine574013-66-4C32H36N2O3
MLN9708;Ixazomib Citrate1201902-80-8C20H23BCl2N2O9
U-104;MST-104;NSC-213841;U104;U 104178606-66-1C13H12FN3O3S
Apilimod;STA 5326541550-19-0C23H26N6O2
OAC26019-39-2C15H12N2O
RGW 6116497-78-5C9H14N4O3
Dihydroethidium;Hydroethidine;PD-MY 003104821-25-2C21H21N3
CZC-54252;CZC 54252;CZC542521191911-27-9C22H25ClN6O4S
MC1568852475-26-4C17H15FN2O3
A-803467;A803467;A 803467944261-79-4C19H16ClNO4
HDAC-IN-7;HBI-8000;CS055;Chidamide743420-02-2C22H19FN4O2
CYM54421094042-01-9C23H27N3O4
ISRIB548470-11-7C22H24Cl2N2O4
NG 52;NG52;NG-52;Compound 52212779-48-1C16H19ClN6O
Bohemine189232-42-6C18H24N6O
Tiplaxtinin;PAI-039;Tiplasinin393105-53-8C24H16F3NO4
NSC-41589;NSC41589;NSC 415896310-41-4C9H11NOS
WHI-P180;Janex 3211555-08-7C16H15N3O3
BML-277;C 3742;BML277;BML 277;Chk2 Inhibitor II516480-79-8C20H14ClN3O2
AG1557;AG-1557;AG 1557189290-58-2C16H14IN3O2
WHI-P25821561-09-1C16H15N3O2
6-OAU;GTPL584683797-69-7C12H21N3O2
TH5881609960-31-7C13H12Cl2N4
RG108;N-Phthalyl-L-tryptophan48208-26-0C19H14N2O4
GSK-923295;GSK9232951088965-37-0C32H38ClN5O4
OAC1;BAS 00287861300586-90-7C14H11N3O
PD153035;ZM 252868;NSC 669364;AG1517;SU-5271153436-54-5C16H14BrN3O2
CTX-0294885;CTx02948851439934-41-4C22H24ClN7O
Mutant IDH1-IN-1;IDH1-IN-11355326-21-4C30H31FN4O2
Varespladib;LY315920172732-68-2C21H20N2O5
JANEX-1;WHI-P131;Jak3 inhibitor I202475-60-3C16H15N3O3
Nimorazole;Nimorazol;Naxogin;K-1900;Nitrimidazine6506-37-2C9H14N4O3
AG-1478;AG1478;AG 1478;Tyrphostin AG-1478;NSC 693255153436-53-4C16H14ClN3O2
LY-364947;LY 364947;LY364947;HTS466284396129-53-6C17H12N4
GS967;GS4589671262618-39-2C14H7F6N3O
PF-06447475;PF06447475;PF 064474751527473-33-1C17H15N5O
WS31421227-52-2C28H30F3N7O3
SKLB4771;FLT3-?IN-?1;FLT3-IN-11370256-78-2C25H27N7O3S2
ADX-47273;ADX 47273;BA 94673139851881-60-2C20H17F2N3O2
KY021111118807-13-8C18H17ClN2O3S
VEGFR-2-IN-5;UNC0064-12;2,4-Pyrimidinediamine with linker;2, 4-Pyrimidinediamine with linker1430089-64-7C19H24N8
Altiratinib;DCC-27011345847-93-9C26H21F3N4O4
Copyright 2019 © ChemicalBook. All rights reserved